MedPath
HSA Approval

ENTECAVIR SANDOZ FILM-COATED TABLET 0.5MG

SIN15548P

ENTECAVIR SANDOZ FILM-COATED TABLET 0.5MG

ENTECAVIR SANDOZ FILM-COATED TABLET 0.5MG

September 24, 2018

NOVARTIS (SINGAPORE) PTE LTD

SANDOZ SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantNOVARTIS (SINGAPORE) PTE LTD
Licence HolderSANDOZ SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

J05AF10

entecavir

Manufacturer Information

SANDOZ SINGAPORE PTE. LTD.

Lek Pharmaceuticals d.d. (Ljubljana)

Active Ingredients

Entecavir

0.5mg

Entecavir

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ENTECAVIR SANDOZ FILM-COATED TABLET 0.5MG - HSA Approval | MedPath